Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients

Neurology

Volumn 52, Issue 5, 1999, Pages 995-1003

  Meyerhoff, Dieter J ^a,c   Bloomer, C ^d   Cardenas, V ^a   Norman, D ^a   Weiner, M W ^a,b   Fein, G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHOLINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAY MATTER; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFORMANCE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0033596808     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.5.995     Document Type: Article

References (42)

1. Heaton RK, Grant I, Butters N, et al. The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc 1995;1(3):231-251.
2. Pumarola-Sune T, Navia BA, Cordon-Cardo B, Cho ES, Price RW HIV antigen in the brains of patients with AIDS dementia complex. Ann Neurol 1987;21:490-496.
3. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988;239:586-592.
4. Kure K, Weidenheim KM, Lyman WD, Dickson DW. Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta Neuropathol 1990;80:393-400.
5. Smith TW, DeGirolami U, Henin D, Bolgert F, Hauw JJ. Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J Neuropathol Exp Neurol 1990;49: 359-370.
6. Masliah E, Achin CL, Ge N, et al. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 1992;32:321-329.
7. Liuzzi GM, Mastroianni CM, Fanelli M, et al. Myelin degrading activity in the CSF of HIV-1-infected patients with neurological diseases. Neuroreport 1994;6:157-160.
8. 1H MR spectroscopic imaging study. AJNR Am J Neuroradiol 1996;17:973-978.
9. 1H magnetic resonance spectroscopic study. Neurology 1996;46:783-788.
10. Jarvik JG, Lenkinski RE, Saykin AJ, Jaans A, Frank I. Proton spectroscopy in asymptomatic HIV-infected adults: initial results in a prospective cohort study. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:247-253.
11. Castro KG, Ward J, Slutsker L, et al. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Atlanta, GA: United States Department of Health and Human Services, CDC, 1992.
12. Powell DH, Kaplan EF, Whitla D, Weinstraub S, Catlin R, Funkenstein HH. MicroCog assessment of cognitive functioning. San Antonio, TX: The Psychological Corporation, 1993.
13. Beck AT, Ward CH, Mendelson M, Erbaugh JK. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
14. Shipley WC. A self-administering scale for measuring intellectual impairment and deterioration. J Psychol 1940;9:371-377.
15. Osterrieth PA. Le test de copie d'une figure complex. Arch Psychol 1944;30:206-356.
16. Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery. Tucson: Neuropsychology Press, 1985.
17. Wechsler D. WAIS-R Psychological Corporation. San Antonio, TX: The Psychological Corporation, 1981.
18. Benton AL, Hamsher KD. Multilingual aphasia examination: manual of instructions. Iowa City: University of Iowa, 1978.
19. Trites RL. Neuropsychological test manual. Ottawa: Royal Ottawa Hospital, 1977.
20. Wetzel L, Boll T. Short Category Test, booklet format. Los Angeles: Western Psychological Services, 1987.
21. Stroop JR. Studies of interference in serial verbal reaction. J Exp Psychol 1935;18:643-662.
22. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 1987;508:333-348.
23. Maudsley AA, Matson GB, Hugg JW, Weiner MW. Reduced phase encoding in spectroscopic imaging. Magn Reson Med 1994;31:645-651.
24. Maudsley AA, Lin E, Weiner MW. Spectroscopic imaging display and analysis. Magn Reson Imag 1992;10:471-485.
25. Lopez-Villegas D, Lenkinski RE, Frank I. Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy. Proc Natl Acad Sci USA 1997;94:9854-9859.
26. Grant I, Martin A. Neuropsychology of HIV infection. New York: Oxford University Press, 1994.
27. Wiley CA, Masliah E, Morey M, et al. Neocortical damage during HIV infection. Ann Neurol 1991;29:651-657.
28. Masliah E, Ge N, Morey M, DeTeresa R, Terry RD, Wiley CA. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest 1992;66:285-291.
29. Everall IP, Glass JD, McArthur J, Spargo E, Lantos P. Neuronal density in the superior frontal and temporal gyri does not correlate with degree of human immunodeficiency virus-associated dementia. Acta Neuropathol 1994;88:538-544.
30. Weis S, Haug H, Budka H. Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study. Acta Neuropathol 1993;85:185-189.
31. Nielsen-Bohlman L, Boyle D, Biggins C, Ezekiel F, Fein G. Semantic priming impairment in HIV. J Int Neuropsychol Soc 1997;3:348-358.
32. Fein, G, Biggins CA, MacKay S. Delayed latency of the event-related brain potential P3A component in HIV disease. Arch Neurol 1995;52:1109-1118.
33. DiSclafani V, MacKay RDS, Meyerhoff DJ, Norman D, Weiner MW, Fein G. Brain atrophy in HIV infection is more strongly associated with CDC clinical stage than with cognitive impairment. J Int Neuropsychol Soc 1997;3:276-287.
34. Navia BA, Gonzalez RG. Functional imaging of the AIDS dementia complex and the metabolic pathology of the HIV-1-infected brain. Neuroimaging Clin North Am 1997;7:431-445.
35. Chong WK, Sweeney B, Wilkinson ID, et al. Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. Radiology 1993;188: 119-124.
36. Menon DK, Ainsworth JG, Cox IJ, et al. Proton MR spectroscopy of the brain in AIDS dementia complex. J Comput Assist Tomogr 1992;16:538-542.
37. 1H magnetic resonance spectroscopic imaging. Neurology 1993;43:509-515.
38. Jarvik JG, Lenkinski RE, Grossman RI, Gomori JM, Schnall MD, Frank I. Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlations. Radiology 1993;186:739-744.
39. 1H MRSI in cognitively impaired HIV-seropositive individuals. Magn Reson Imaging 1994;12:653-659.
40. Chong WK, Paley M, Wilkinson ID, et al. Localized cerebral proton MR spectroscopy in HIV infection and AIDS. AJNR Am J Neuroradiol 1994;15:21-25.
41. Wiley CA, Achim C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 1994;36:673-676.
42. Wilkinson ID, Miller RF, Miskiel KA, et al. Cerebral proton magnetic resonance spectroscopy in asymptomatic HIV infection. AIDS 1997;11:289-295.